HOME >> MEDICINE >> NEWS
Penn researchers announce results of Phase I trial using combretastatin drug

(Philadelphia, PA) -- New approaches are needed to treat solid malignant tumors that cannot be removed surgically and are resistant to traditional powerful chemotherapy drugs. In a Phase I clinical trial, a team of researchers at the University of Pennsylvania Cancer Center has found that patients with solid cancerous tumors were able to safely tolerate a new drug, originally derived from a South African willow bush, that interacts with the tumor's blood supply. James P. Stevenson, MD, assistant professor of medicine at Penn and lead author of the study, will present these findings at the 91st American Association of Cancer Research Meeting on Tuesday, April 4, 2000 in San Francisco.

Combretastatin A4 phosphate is a drug that is classified as a vascular targeting agent. It selectively targets and reduces or destroys blood vessels supplying malignant tumors while sparing the vasculature of normal tissues. Vascular targeting agents like combretastatin attack proliferating blood vessels that already exist, whereas angiogenesis inhibitors generally stop new blood vessels from developing.

In this study, 29 patients with a range of solid tumors, unresponsive to traditional chemotherapy, were treated with a daily intervenous dose of combretastatin for five consecutive days every three weeks. All of the patients were given CT scans before and at the end of the treatment cycle to determine changes in tumor blood supply. Nine patients who were given the highest dose of combretastatin were monitored via MRI. Dr. Stevenson's team found evidence of a decrease in blood flow to the tumor following combretastatin therapy in five of the nine patients who were followed by MRI.

"These early results are promising and suggest that combretastatin may affect tumor blood supply," says Stevenson. "We will continue investigating this drug for its potential benefits in fighting advanced cancers."

T
'"/>

Contact: Sue Montgomery
sue.montgomery@uphs.upenn.edu
215-349-5657
University of Pennsylvania School of Medicine
3-Apr-2000


Page: 1 2

Related medicine news :

1. Indiana University researchers closer to helping hearing-impaired using stem cells
2. Protein that helps skin cancer spread identified by Stanford researchers
3. US life expectancy about to decline, researchers say
4. Gene for age-related macular degeneration discovered by Yale researchers
5. Dartmouth researchers find where musical memories are stored in the brain
6. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
7. US cancer researchers launch first American-Israeli cancer conference
8. USC dental researchers develop first test for predicting cavities in children
9. Young blood revives aging muscles, Stanford researchers find
10. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
11. Age should not be a factor in determining heart transplantation eligibility, researchers say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... 19, 2019 , ... Marking a key milestone in the ... on Wednesday will lift into place the final steel beam at AHN ... year. , The nearly 79,000-square-foot facility – located at 6321 Route 30, Greensburg, ...
(Date:2/19/2019)... HILLS, Calif. (PRWEB) , ... February 19, 2019 ... ... Wachler Vision Institute, Brian Boxer Wachler, MD, has launched the first ever supplement ... that can lead to severe to severe vision loss. The supplement, KC Defense, ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... with town halls across the country , A partnership between Liberty University and ... crisis, continues with its next town hall event on Tuesday, February 19, at ...
(Date:2/19/2019)... JACKSONVILLE, Fla. (PRWEB) , ... February 19, 2019 ... ... professors say yes! , “Nova Filtration is based in The Villages FL proudly ... success in our new franchised Territory in the greater Jacksonville area selling and ...
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Lombardi is ... Oncology Institute of Hope and Innovation. , Dr. Lombardi completed his undergraduate in ... received his medical degree from the University of Rochester School of Medicine. He ...
Breaking Medicine News(10 mins):
(Date:2/16/2019)... ... February 15, 2019 , ... ... Allison Marlow of Perio-Implant Care are urging patients to take their oral health ... cancers, diabetes, Alzheimer's and dementia, and risk of pre-term birth, there is plenty ...
(Date:2/16/2019)... ... 15, 2019 , ... Dr. Lucas Bryant, board-certified Face expert ... Haute Beauty Network, well known for their exclusivity, and luxurious lifestyle, is privileged ... newest addition to the Haute Living partnership. , Haute Beauty offers a prominent ...
(Date:2/14/2019)... Colo. (PRWEB) , ... February 14, 2019 , ... ... Month , Lewis and Clark College Emeritus Professor of Education Gregory A. Smith ... They discuss the emergence of Brand Ambassador programs, a new phenomenon in the ...
Breaking Medicine Technology:
Cached News: